Education
About Us
Working with TipRanks
Follow Us
Genedx Holdings Corp. (WGS)
:WGS
Earnings Data
Report Date
Aug 18, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.13Last Year’s EPS
-0.11Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Date:Apr 30, 2025
|% Change Since: -45.25%
|Next Earnings Date:Aug 18, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, profitability, and strategic advancements like the Fabric Genomics acquisition. However, challenges such as weather impacts on volumes and increased G&A expenses were noted. The company's positive momentum and strategic initiatives outweigh these challenges.Company Guidance
During the GeneDx First Quarter 2025 Earnings Conference Call, the company shared several key metrics and updates. GeneDx reported first-quarter revenues of $87.1 million, with exome and genome revenues growing 62% year-over-year to $71.4 million. The company raised its full-year 2025 revenue guidance to between $360 million and $375 million, reflecting strong momentum, particularly in exome and genome testing, which accounted for 40% of all tests conducted in the quarter. GeneDx also highlighted its strategic acquisition of Fabric Genomics, which is expected to contribute $3 million to $5 million in revenue and expand the company's capabilities in AI-powered genomic interpretation. The average reimbursement rate for exome and genome testing rose to approximately $3,400 from $2,600 in the previous year, driven by reduced denials and positive beats on past estimates. The company maintained a strong gross margin of 69%, up from 61% a year ago, and achieved its third consecutive quarter of profitability with an adjusted net income of $7.7 million. GeneDx emphasized its ongoing efforts to expand into new clinical indications and its commitment to driving better clinical outcomes while reducing healthcare costs.Strong First Quarter Revenue and Profitability
GeneDx reported first-quarter revenues exceeding $87 million and achieved its third consecutive quarter of profitability. Exome and genome revenues grew 62% year-over-year.
Raising Full-Year Revenue Guidance
The company raised its full-year 2025 revenue guidance to $360 million to $375 million, reflecting confidence in continued momentum and market leadership.
Significant Growth in Exome and Genome Testing
Volumes from flagship products increased by 24% year-over-year, contributing $71.4 million in revenue. The company expects at least 30% growth in exome genome volume and revenues for full year 2025.
Successful Launch of Ultra Rapid Genome Sequencing
GeneDx launched an ultra rapid genome sequencing product with a 48-hour turnaround time, enhancing its service offering in the NICU.
Positive Reimbursement Trends
Average reimbursement rate for exome and genome tests increased to approximately $3,400, up from $2,600 in the same quarter last year.
Strategic Acquisition of Fabric Genomics
GeneDx announced plans to acquire Fabric Genomics to enhance its AI-powered genomic interpretation capabilities and expand into international markets.
WGS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
WGS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 30, 2025 | $116.97 | $66.85 | -42.85% |
Feb 18, 2025 | $76.35 | $112.76 | +47.69% |
Oct 29, 2024 | $56.06 | $84.02 | +49.88% |
Jul 30, 2024 | $30.13 | $32.72 | +8.60% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Genedx Holdings Corp. (WGS) report earnings?
Genedx Holdings Corp. (WGS) is schdueled to report earning on Aug 18, 2025, TBA Not Confirmed.
What is Genedx Holdings Corp. (WGS) earnings time?
Genedx Holdings Corp. (WGS) earnings time is at Aug 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is WGS EPS forecast?
WGS EPS forecast for the fiscal quarter 2025 (Q2) is 0.13.